These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 779054)

  • 1. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J; Buckle JW; Turner J; Cohen M
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients.
    Yajnik VH; Patel SC
    Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454
    [No Abstract]   [Full Text] [Related]  

  • 5. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
    Yajnik BH; Shah JS
    J Assoc Physicians India; 1985 May; 33(5):339-43. PubMed ID: 3900029
    [No Abstract]   [Full Text] [Related]  

  • 6. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoramin in the treatment of pregnancy hypertension. A placebo-controlled trial comparing the efficacy of indoramin with alpha-methyldopa.
    Anthony J; Rees AE; Davey DA
    S Afr Med J; 1990 Oct; 78(8):458-61. PubMed ID: 2218781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
    Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
    Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoramin as second step therapy in the management of benign essential hypertension.
    Montenero AS; Mazzari M; Schiavoni G; Manzoli U; Gherardi S
    Pharmatherapeutica; 1983; 3(6):417-21. PubMed ID: 6353433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A; Stumpe KO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of indoramin on exercise performance in mild hypertension.
    Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.
    Stokes GS; Frost GW; Graham RM; MacCarthy EP
    Clin Pharmacol Ther; 1979 Jun; 25(6):783-9. PubMed ID: 36250
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.